Misao Ōwada

1.7k total citations
70 papers, 1.3k citations indexed

About

Misao Ōwada is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Misao Ōwada has authored 70 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Physiology and 18 papers in Clinical Biochemistry. Recurrent topics in Misao Ōwada's work include Lysosomal Storage Disorders Research (20 papers), Metabolism and Genetic Disorders (18 papers) and Diabetes Management and Research (11 papers). Misao Ōwada is often cited by papers focused on Lysosomal Storage Disorders Research (20 papers), Metabolism and Genetic Disorders (18 papers) and Diabetes Management and Research (11 papers). Misao Ōwada collaborates with scholars based in Japan, United States and United Kingdom. Misao Ōwada's co-authors include Teruo Kitagawa, Tatsuhiko Urakami, Elizabeth F. Neufeld, Kuniaki Yamauchi, Takeshi Sakiyama, Kensuke Harada, Naoko Tajima, Shigeo Morimoto, Fumio Endo and M. Tsuda and has published in prestigious journals such as Diabetes Care, Biochemical and Biophysical Research Communications and Journal of Nutrition.

In The Last Decade

Misao Ōwada

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misao Ōwada Japan 19 470 460 363 343 218 70 1.3k
Yuan‐Tsong Chen United States 15 458 1.0× 138 0.3× 316 0.9× 501 1.5× 87 0.4× 25 1.4k
Jean‐Marie Villette France 20 314 0.7× 523 1.1× 174 0.5× 441 1.3× 116 0.5× 38 1.4k
C R Kahn United States 10 349 0.7× 131 0.3× 60 0.2× 538 1.6× 160 0.7× 13 901
Rector Arya United States 19 223 0.5× 250 0.5× 523 1.4× 533 1.6× 249 1.1× 47 1.4k
Melanie K. Shadoan United States 19 225 0.5× 683 1.5× 213 0.6× 586 1.7× 496 2.3× 27 1.5k
William S. Garver United States 21 952 2.0× 56 0.1× 142 0.4× 434 1.3× 270 1.2× 38 1.5k
Jean‐Pierre Felber Switzerland 17 752 1.6× 327 0.7× 64 0.2× 485 1.4× 211 1.0× 27 1.4k
Toshihiro Ohura Japan 27 654 1.4× 212 0.5× 305 0.8× 1.5k 4.3× 351 1.6× 90 3.0k
H Gröbe Germany 11 119 0.3× 195 0.4× 160 0.4× 237 0.7× 109 0.5× 30 680
A Labhart Switzerland 17 239 0.5× 589 1.3× 162 0.4× 498 1.5× 271 1.2× 66 1.3k

Countries citing papers authored by Misao Ōwada

Since Specialization
Citations

This map shows the geographic impact of Misao Ōwada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misao Ōwada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misao Ōwada more than expected).

Fields of papers citing papers by Misao Ōwada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misao Ōwada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misao Ōwada. The network helps show where Misao Ōwada may publish in the future.

Co-authorship network of co-authors of Misao Ōwada

This figure shows the co-authorship network connecting the top 25 collaborators of Misao Ōwada. A scholar is included among the top collaborators of Misao Ōwada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misao Ōwada. Misao Ōwada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondo, Yuichi, et al.. (2013). Liver cirrhosis treated by living donor liver transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA. Clinica Chimica Acta. 424. 19–21. 5 indexed citations
2.
Sato, Yuki, Shohei Harada, Naoko Kakee, et al.. (2009). Attitude to extended use and long‐term storage of newborn screening blood spots in Japan. Pediatrics International. 52(3). 393–397. 9 indexed citations
3.
Kitagawa, Teruo, Ken Suzuki, Nobuyuki Ishige, et al.. (2008). Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes. Pediatric Nephrology. 23(9). 1461–1471. 16 indexed citations
4.
Urakami, Tatsuhiko, Shigeo Morimoto, Misao Ōwada, & Kensuke Harada. (2005). Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus. Pediatrics International. 47(4). 430–433. 21 indexed citations
5.
Kitagawa, Teruo, Nobuyuki Ishige, Ken Suzuki, et al.. (2005). Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. Molecular Genetics and Metabolism. 85(3). 196–202. 48 indexed citations
6.
Murakami, Nobuyuki, Ryoichi Sakuta, Toshiro Nagai, et al.. (2005). Early onset distal muscular dystrophy with normal dysferlin expression. Brain and Development. 27(8). 589–591. 2 indexed citations
7.
8.
Urakami, Tatsuhiko, et al.. (2004). Optimal use of quick-acting insulin analogue in combination with basal insulin and its long-term effect in Japanese children and adolescents with type 1 diabetes. Diabetes Research and Clinical Practice. 68(2). 96–103. 1 indexed citations
9.
Tsuda, M., Kenichi Horinouchi, Takeshi Sakiyama, & Misao Ōwada. (2002). Novel missense mutation in the purine nucleoside phosphorylase gene in a Japanese patient with purine nucleoside phosphorylase deficiency. Pediatrics International. 44(3). 333–334. 2 indexed citations
10.
Ōwada, Misao, et al.. (2002). Mass screening for Wilson's disease by measuring urinary holoceruloplasmin. The Journal of Pediatrics. 140(5). 614–616. 23 indexed citations
11.
Ōwada, Misao, Kikumaro Aoki, & Teruo Kitagawa. (2000). Taste preferences and feeding behaviour in children with phenylketonuria on a semisynthetic diet. European Journal of Pediatrics. 159(11). 846–850. 20 indexed citations
12.
Tsuda, M., Mizuho Kaneda, Takeshi Sakiyama, et al.. (1998). A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b 558 in atypical X-linked chronic granulomatous disease. Human Genetics. 103(4). 377–381. 15 indexed citations
13.
Ikeda, Hiroyuki, Yoichi Matsubara, Hitoshi Mikami, et al.. (1997). Molecular analysis of dihydropteridine reductase deficiency: identification of two novel mutations in Japanese patients. Human Genetics. 100(5-6). 637–642. 16 indexed citations
14.
Tsuda, M., et al.. (1996). A newly identified exonic mutation of the WT1 gene in a patient with Denys‐Drash syndrome. Pediatrics International. 38(3). 265–266. 3 indexed citations
15.
Ashida, Akira, Misao Ōwada, & Kazuyuki Hatakeyama. (1994). A Missense Mutation (A to G) of 6-Pyruvoyltetrahydropterin Synthase in Tetrahydrobiopterin-Deficient Form of Hyperphenylalaninemia. Genomics. 24(2). 408–410. 7 indexed citations
16.
Uyama, Eiichiro, Tetsuya Terasaki, Susumu Watanabe, et al.. (1992). Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. Acta Neurologica Scandinavica. 86(6). 609–615. 21 indexed citations
17.
Ōwada, Misao, et al.. (1991). Autosomal Recessive Polycystic Kidney in Rats. ˜The œNephron journals/Nephron journals. 59(4). 637–640. 9 indexed citations
18.
Nishiguchi, Shuhei, et al.. (1989). A female case of type VIII glycogenosis who developed cirrhosis of the liver and hepatocellular tumor. Gastroenterologia Japonica. 24(6). 711–714. 7 indexed citations
19.
Kitagawa, Teruo, Misao Ōwada, Kikumaro Aoki, et al.. (1987). Treatment of Phenylketonuria with a Formula Consisting ofLow-Phenylalanine Peptide. Enzyme. 38(1-4). 321–327. 14 indexed citations
20.
Abe, Kenji, et al.. (1980). Cytoplasmic blood plasma inclusions of hepatocytes associated with idiopathic portal hypertension-report of a case. Kanzo. 21(10). 1358–1365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan‐Tsong Chen Breakdown of academic impact, for papers by Jean‐Marie Villette Breakdown of academic impact, for papers by C R Kahn Breakdown of academic impact, for papers by Rector Arya Breakdown of academic impact, for papers by Melanie K. Shadoan Breakdown of academic impact, for papers by William S. Garver Breakdown of academic impact, for papers by Jean‐Pierre Felber Breakdown of academic impact, for papers by Toshihiro Ohura Breakdown of academic impact, for papers by H Gröbe Breakdown of academic impact, for papers by A Labhart
Rankless by CCL
2026